Over the past couple of years, the U.S. Food and Drug Administration (FDA) has taken a hard-line stance against drug products that were approved under the accelerated approval pathway, but have not met their post-marketing or confirmatory trial commitments.Read More

Dr. Suzan McNamara knew she was too young to die. At 31, she was diagnosed with a rare disease called Chronic Myeloid Leukemia (CML), and was given only three to five years to live.Read More

In May 2016, Lee-Anne Pickard, a nurse with close to 20 years of experience in cancer research, was sent an article from the Montreal Gazette. It outlined how Exactis had set up a pan-Canadian network to collect samples from patients for molecular testing in the hopes of matching them to clinical trials. It was her...Read More